Compounds having both angiotensin ii receptor antagonism and...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 471/04 (2006.01) A61K 31/437 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2671943

Compounds of following formula (I) are provided that have both angiontensin Il receptor antagonist activity and PPARy agonist activity. Also provided are pharmaceutical compositions comprising the compounds and methods of treatment of diseases with the compounds including type 2 diabetes, insulin resistance, hyperinsulinemia, hyperlipidemia, hypertriglyceridemia, metabolic syndrome, congestive heart failure, and hypertension.

La présente invention concerne des composés de la formule ci-dessous qui ont à la fois une activité d'antagoniste du récepteur de l'angiotensine II et une activité d'agoniste du PPARy. L'invention concerne également des compositions pharmaceutiques comprenant les composés et des procédés de traitement avec les composés de maladies comprenant le diabète de type 2, l'insulinorésistance, l'hyperinsulinémie, l'hyperlipidémie, l'hypertriglycéridémie, le syndrome métabolique, l'insuffisance cardiaque congestive et l'hypertension.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Compounds having both angiotensin ii receptor antagonism and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds having both angiotensin ii receptor antagonism and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds having both angiotensin ii receptor antagonism and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1620052

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.